GTBP icon

GT Biopharma

34 hedge funds and large institutions have $4.36M invested in GT Biopharma in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$58K
2 +$44K
3 +$35.2K
4
Goldman Sachs
Goldman Sachs
New York
+$25.3K
5
State Street
State Street
Massachusetts
+$15.3K

Top Sellers

1 -$242K
2 -$193K
3 -$183K
4
Citadel Advisors
Citadel Advisors
Florida
-$182K
5
Millennium Management
Millennium Management
New York
-$159K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.98M
2
$654K
3
$394K
4
$271K
5
$181K
6
$167K
7
$121K
8
$91K
9
$88K
10
$58K
11
$58K
12
$44K
13
$44K
14
$38K
15
$31K
16
$26K
17
$23K
18
$21K
19
$19K
20
$18K
21
$9K
22
$5K
23
$5K
24
$3K
25
$2K